Tapering 7.5 mg Mirtazapine
For a 7.5 mg dose of mirtazapine, gradually taper by reducing to 3.75 mg (half the dose) for 2 weeks, then switch to 3.75 mg every other day for 2 weeks, followed by 3.75 mg every 4 days before complete discontinuation. 1
Rationale for This Approach
The FDA label explicitly states that mirtazapine should be "gradually reduced rather than stopped abruptly whenever possible" to prevent discontinuation syndrome 1. At 7.5 mg, you're already at the lowest standard tablet dose, which requires a more nuanced tapering strategy than simply cutting the dose in half once.
Why This Specific Schedule
Initial reduction to 3.75 mg: This represents a 50% dose reduction, which aligns with general antidepressant tapering principles 2. The 2-week interval allows sufficient time to assess tolerance to the reduction 1.
Alternating day dosing: After reaching 3.75 mg daily, switching to every-other-day dosing for 2 weeks further reduces exposure while maintaining some medication effect. This mirrors successful tapering strategies used with other antidepressants 2.
Every 4-day dosing: The final step before complete cessation. This minimizes the pharmacological "jump" to zero, which is critical given mirtazapine's half-life of 20-40 hours.
Critical Considerations
Withdrawal Risk
Case reports document severe panic attacks occurring within 2 days of abrupt mirtazapine discontinuation, even after only 10 weeks of treatment at 30 mg 3. While your patient is on a lower dose (7.5 mg), the risk of discontinuation symptoms remains, particularly if they've been on treatment for several months.
Common withdrawal symptoms include: dizziness, abnormal dreams, sensory disturbances (paresthesia, electric shock sensations), agitation, anxiety, fatigue, confusion, headache, tremor, nausea, vomiting, and sweating 1.
Monitoring Schedule
- Follow-up every 2 weeks during active tapering to assess for withdrawal symptoms
- If withdrawal symptoms emerge, pause the taper at the current dose until symptoms resolve, then resume at a slower pace
- Distinguish withdrawal symptoms from depression relapse: withdrawal typically occurs within days of dose reduction and improves over 1-2 weeks, while relapse develops more gradually
Practical Implementation
Since 3.75 mg tablets aren't commercially available, you'll need to:
- Use a pill cutter to split 7.5 mg tablets (though this may be imprecise)
- Consider liquid formulation if available for more accurate dosing
- Alternatively, compound 3.75 mg capsules through a compounding pharmacy
When to Slow Down Further
If the patient experiences significant withdrawal symptoms with the above schedule, extend each reduction phase to 4 weeks instead of 2 weeks. Some patients, particularly those on mirtazapine for over a year or with prior difficult discontinuation attempts, may require even slower tapering over several months 4, 5.
Red Flags Requiring Pause or Reversal
- Severe anxiety or panic attacks
- Suicidal ideation
- Insomnia lasting more than 3-4 days
- Intolerable physical symptoms (severe nausea, dizziness preventing daily activities)
If these occur, return to the previous tolerated dose and maintain for 2-4 weeks before attempting a slower taper.
Alternative for High-Risk Patients
For patients with prior failed discontinuation attempts or significant anxiety about stopping, consider a more conservative hyperbolic taper: reduce by 25% of the current dose every 2-4 weeks. This would mean: 7.5 mg → 5.6 mg → 4.2 mg → 3.2 mg → 2.4 mg → 1.8 mg → 1.3 mg → 1 mg → 0.5 mg → stop. This requires liquid formulation or compounding but minimizes withdrawal risk 4, 5, 6.